Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare, Cell Biosciences, Proxeon

Premium
GE Healthcare this week launched four new custom-designed BioProcess affinity chromatography media for industrial-scale purifications of various biopharmaceuticals.
 
They are KappaSelect for antibody fragments for kappa light chain; IgSelect for human IgG; AVB Sepharose High Performance for adeno-associated virus; and VIIISelect for Factor VIII production.
 
The new media are based on the use of immobilized single-chain antibody fragments as chromatography ligands. BAC, which develops and produces antibody fragments for use in the manufacture of biopharmaceuticals, collaborated with GE in developing the media.
 
GE’s Custom-Design Media program used the antibody fragments developed by BAC to develop chromatography resins. The program is available to manufacturers to request additional custom media for purification work, GE said in a statement.
 

 
Cell Biosciences this week launched the Firefly 3000 Focusing kits, Detection kits, and Plate kits for the Firefly 3000 Protein Analysis System.
 
The kits are the first assays kits for the system and were designed to provide reproducible analytical results conveniently and flexibly, company said in a statement.
 
They are available with multiple separation ranges and multiple detection antibodies.
 

 
Proxeon this week released ProteinCenter 2.0, an interpretation tool that converts complex proteomics datasets into biological sense in minutes rather than months with conventional solutions.
 
ProteinCenter 2.0 allows researchers to share datasets with colleagues and collaborators remotely and can “reveal the biological picture concealed within each dataset by enabling comparison of datasets against complete proteomes,” Proxeon said in a statement.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.